Z-0350-2023 Class III Terminated

Recalled by Primus Corporation dba Trinity Biotech — Kansas City, MO

Recall Details

Product Type
Devices
Report Date
December 7, 2022
Initiation Date
October 5, 2021
Termination Date
August 9, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
182 kits

Product Description

Trinity Biotech HbA1c (GHb) Contorls Kit, 500uL (Levels I & II), REF 01-04-0020, Part number 05-01-0040B, A1c analysis

Reason for Recall

The Control Level I material value was showing results exceeding the upper limit of the acceptable range after a period of three (3) months. Additionally, per the firm, the unacceptable Control Level 1 value results in the Analyzer generating an error code which stops further testing and nullifies associated patient samples, resulting in a delay in patient results and a potential delay in therapeutic modifications.

Distribution Pattern

Turkey, India, Romania, Thailand, Vietnam, S. Korea, Peru, Pakistan Austria, UAE, Chile, Italy.

Code Information

UDI/DI 0539151674808, Lot 12161